These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 10636369

  • 21. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K.
    Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
    [Abstract] [Full Text] [Related]

  • 22. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD, Lawrenson RA.
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [Abstract] [Full Text] [Related]

  • 23. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 24. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST.
    Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404
    [Abstract] [Full Text] [Related]

  • 25. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R.
    Contraception; 1985 Apr 01; 31(4):395-408. PubMed ID: 3159546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE.
    Contraception; 1994 Jan 01; 49(1):33-46. PubMed ID: 8137624
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar 01; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 30. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Mar 01; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 31. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J, Exalto N, Dieben T, Bennink HC.
    Contraception; 1995 Dec 01; 52(6):357-61. PubMed ID: 8749599
    [Abstract] [Full Text] [Related]

  • 32. Effect of the oral contraceptive pill on protein S and antithrombin-III levels in Malaysian women.
    Wong KK, Ng SC, Koong PL.
    Med Sci Res; 1995 Dec 01; 20(12):439-40. PubMed ID: 12288974
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
    Coates PE, Mesure R.
    Br J Clin Pharmacol; 1995 Dec 01; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
    [Abstract] [Full Text] [Related]

  • 35. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M, Robinson G, Bounds W, Newman B, Guillebaud J.
    Contraception; 1993 Apr 01; 47(4):367-76. PubMed ID: 8508666
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov 01; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 38. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
    Rosing J, Tans G, Nicolaes GA, Thomassen MC, van Oerle R, van der Ploeg PM, Heijnen P, Hamulyak K, Hemker HC.
    Br J Haematol; 1997 Apr 01; 97(1):233-8. PubMed ID: 9136971
    [Abstract] [Full Text] [Related]

  • 39. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.
    Contraception; 1996 Jul 01; 54(1):5-13. PubMed ID: 8804801
    [Abstract] [Full Text] [Related]

  • 40. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.